InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,634.61
(
1.15%
)
US TECH 100
19,202.80
(
1.10%
)
Dow Jones
41,175.08
(
1.14%
)
Brent Oil
78.38
(
0.00%
)
Bitcoin
63,916.34
(
-0.39%
)
Post# of 43293
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Fezziwig2008

Send PM Follow Ignore
Followers 24
Posts 501
Boards Moderated 1
Alias Born 03/09/2014

Fezziwig2008

Re: None

Sunday, 09/06/2020 12:22:21 PM

Sunday, September 06, 2020 12:22:21 PM

Post# of 43293
Fact Based Investing- “ The NIH confirmed to GEN it has awarded contracts totaling $25.8 million to Leidos Biomedical Research toward managing, overseeing, and conducting the trial, the most recent being $14.3 million awarded on August 4. As for the Phase III study, it is about halfway through enrollment, and expected to finish by end of September or early October, with data expected to be released about a month later.”

https://www.genengnews.com/gen-edge/a-human-touch-vs-covid-19/

I’m Betting on BET - adding Anti-GMCSF to weak antiviral Remdesivir is BETter than Rem alone.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up